Lurie Cancer Center Member
Kalliopi Siziopikou, MD, PhD
Professor, Pathology; Feinberg School of Medicine
View Publications Listing
Dr. Siziopikou’s subspecialty focus is on breast tumor markers and molecular diagnostics in breast cancer. Her research interests center around molecular markers of prognostic and predictive significance in breast cancer. Her current research focuses on the delineation of the molecular mechanisms underlying the pathogenesis of triple negative breast cancer, racial differences in the incidence of these triple negative breast cancers, biologic differences in the behavior of breast cancer in young versus older breast cancer patients, the possible mechanisms of preferential homing of breast cancer cells to different metastatic sites and improving pathology-radiology correlation, especially with the recently introduced MRI-guided needle core biopsies. Dr. Siziopikou is the pathologist co-investigator on the NSABP B43 study that is poised to change the paradigm of treatment for women with HER-2 positive DCIS lesions.